EcoDrugPlus

Ensembl ID : ENSPEMG00000003728
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSPEMG00000016907
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSPEMG00000025064
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSPEMG00000030103
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSPEMG00000009669
Gene Symbol: -
Cross references: -
83 Possible Orthologues:

Ensembl ID : ENSPEMG00000003212
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSPEMG00000030544
Gene Symbol: -
Cross references: -
46 Possible Orthologues:

Ensembl ID : ENSPEMG00000029392
Gene Symbol: -
Cross references: -
46 Possible Orthologues:

Ensembl ID : ENSPEMG00000025758
Gene Symbol: -
Cross references: -
34 Possible Orthologues:

Ensembl ID : ENSPEMG00000025066
Gene Symbol: -
Cross references: -
58 Possible Orthologues:

Ensembl ID : ENSPEMG00000024840
Gene Symbol: -
Cross references: -
98 Possible Orthologues:

Ensembl ID : ENSPEMG00000024458
Gene Symbol: -
Cross references: -
58 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).